Visit a quote page and your recently viewed tickers will be displayed here. Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. Its artificial heart is intended for patients with advanced cardiac insufficiency that is ineligible for a transplant and have exhausted all medication alternatives.
Where is Carmat SAS headquartered?
The firm also develops electrical power supply system and telediagnostics system. The company was founded by Pouletty Philippe and Alain Carpentier on June 25, 2008 and is headquartered in Vélizy Villacoublay, France. ALCAR | Complete Carmat SAS stock news by MarketWatch.
Does Carmat participate in scientific and investor conferences?
CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the Seco... CARMAT annonce sa participation à plusieurs conférences scientifiques et investisseurs au cours d... CARMAT Announces a Final Agreement With All Its Financial Creditors on New Repayment Terms for It...
